Fifth Third Bancorp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Sell
38,838
-3,322
-8% -$157K ﹤0.01% 1412
2025
Q4
$2.15M Buy
42,160
+978
+2% +$50K 0.01% 447
2025
Q3
$2.29M Sell
41,182
-2,079
-5% -$122K 0.01% 442
2025
Q2
$2.99M Sell
43,261
-2,810
-6% -$191K 0.01% 378
2025
Q1
$3.2M Sell
46,071
-2,172
-5% -$179K 0.01% 356
2024
Q4
$4.15M Sell
48,243
-171
-0.4% -$18.5K 0.02% 337
2024
Q3
$5.76M Sell
48,414
-4,570
-9% -$609K 0.02% 298
2024
Q2
$7.56M Sell
52,984
-565
-1% -$74.9K 0.03% 261
2024
Q1
$6.88M Sell
53,549
-3,009
-5% -$358K 0.03% 279
2023
Q4
$5.85M Sell
56,558
-3,167
-5% -$313K 0.02% 287
2023
Q3
$5.43M Sell
59,725
-2,793
-4% -$246K 0.03% 291
2023
Q2
$5.06M Sell
62,518
-17,400
-22% -$1.42M 0.02% 317
2023
Q1
$6.36M Buy
79,918
+598
+0.8% +$42.4K 0.03% 294
2022
Q4
$5.37M Sell
79,320
-904
-1% -$53K 0.03% 310
2022
Q3
$4M Sell
80,224
-20,566
-20% -$1.1M 0.02% 331
2022
Q2
$5.62M Sell
100,790
-6,580
-6% -$365K 0.03% 309
2022
Q1
$5.96M Sell
107,370
-2,666
-2% -$137K 0.02% 321
2021
Q4
$6.16M Sell
110,036
-7,730
-7% -$419K 0.02% 321
2021
Q3
$5.65M Sell
117,766
-4,480
-4% -$217K 0.02% 328
2021
Q2
$5.12M Buy
122,246
+4,928
+4% +$191K 0.02% 341
2021
Q1
$3.96M Buy
117,318
+928
+0.8% +$33.1K 0.02% 362
2020
Q4
$4.07M Buy
116,390
+4,080
+4% +$141K 0.02% 353
2020
Q3
$3.9M Sell
112,310
-1,668
-1% -$55.6K 0.02% 351
2020
Q2
$3.73M Sell
113,978
-632
-0.6% -$20.2K 0.02% 344
2020
Q1
$3.45M Sell
114,610
-2,398
-2% -$71.4K 0.02% 319
2019
Q4
$3.39M Sell
117,008
-4,832
-4% -$134K 0.02% 358
2019
Q3
$3.15M Sell
121,840
-4,084
-3% -$103K 0.02% 348
2019
Q2
$3.21M Buy
125,924
+3,952
+3% +$97.7K 0.02% 343
2019
Q1
$3.19M Sell
121,972
-2,562
-2% -$63K 0.02% 328
2018
Q4
$2.87M Sell
124,534
-1,906
-2% -$42.4K 0.02% 326
2018
Q3
$2.98M Sell
126,440
-3,160
-2% -$77.1K 0.02% 335
2018
Q2
$2.99M Sell
129,600
-4,968
-4% -$118K 0.02% 331
2018
Q1
$3.31M Sell
134,568
-156,640
-54% -$4.11M 0.02% 324
2017
Q4
$7.82M Sell
291,208
-5,384
-2% -$137K 0.05% 246
2017
Q3
$7.14M Sell
296,592
-9,852
-3% -$223K 0.05% 248
2017
Q2
$6.57M Sell
306,444
-708
-0.2% -$14.3K 0.05% 248
2017
Q1
$5.26M Buy
307,152
+8,266
+3% +$144K 0.04% 269
2016
Q4
$5.36M Sell
298,886
-58,012
-16% -$1.05M 0.04% 274
2016
Q3
$7.42M Buy
356,898
+6,736
+2% +$167K 0.06% 228
2016
Q2
$9.42M Sell
350,162
-7,086
-2% -$194K 0.08% 207
2016
Q1
$9.68M Sell
357,248
-79,160
-18% -$2.12M 0.08% 208
2015
Q4
$12.7M Sell
436,408
-27,438
-6% -$759K 0.11% 188
2015
Q3
$12.6M Buy
463,846
+22,314
+5% +$632K 0.12% 184
2015
Q2
$12.1M Buy
441,532
+30,358
+7% +$853K 0.11% 189
2015
Q1
$11M Buy
411,174
+7,204
+2% +$166K 0.1% 191
2014
Q4
$8.55M Buy
403,970
+14,226
+4% +$318K 0.07% 227
2014
Q3
$9.28M Buy
389,744
+21,388
+6% +$492K 0.08% 207
2014
Q2
$8.51M Sell
368,356
-21,858
-6% -$483K 0.08% 223
2014
Q1
$8.91M Buy
390,214
+12,024
+3% +$256K 0.08% 201
2013
Q4
$6.99M Buy
378,190
+15,170
+4% +$264K 0.07% 234
2013
Q3
$6.14M Buy
363,020
+46,230
+15% +$778K 0.06% 257
2013
Q2
$4.91M Buy
+316,790
New +$5.27M 0.05% 283

Other funds holding NVO

Fifth Third Bancorp's NVO Position: Q1 2026 in Review

Fifth Third Bancorp reduced its Novo Nordisk (NVO) stake by 7.9% in Q1 2026, selling an estimated $157K and leaving 38,838 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Fifth Third Bancorp first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.7M in Q4 2015. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Fifth Third Bancorp held 38,838 shares of Novo Nordisk worth $1.43M as of Q1 2026.
  • Fifth Third Bancorp sold 3,322 Novo Nordisk shares in Q1 2026, an estimated $157K.
  • Novo Nordisk made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1412 holding.
  • Fifth Third Bancorp first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Fifth Third Bancorp's Novo Nordisk position peaked at $12.7M in Q4 2015.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.